Spermosens AB (publ)

Research Spermosens AB (publ) (9R5) on Bullrun: market cap EUR 634.60K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker9R5
ExchangeF
CountrySweden
SectorHealthcare
IndustryDiagnostics & Research
CurrencyEUR
Market capEUR 634.60K
Financial periodQ1 2026
RevenueSEK 0
Net income-SEK 2.18M
Free cash flow-SEK 2.36M

Valuation Snapshot

latest market cap is EUR 634.60K.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	SEK 0	-SEK 9.20M	-SEK 8.84M	n/a	0	SEK 6.84M	SEK 0	SEK 32.41M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	EUR 634.60K	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Spermosens AB (publ)

Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

ALPHAHELIX MOL.DIAGN. SK1 (4MB) Neovici Holding AB (publ) (IDLDX) Immunovia publ AB (IMMNOV) Prostatype Genomics AB (publ) (PGO0) Prostatype Genomics AB (PROGEN) SenzaGen AB (SENZA) Vimian Group AB (VIMIAN) INIFY LABORATORIES AB (WY60) ODINWELL AB (0AF) Camurus AB (0RD1) Flerie AB (publ) (1NP1) PEPTONIC MEDICAL (28L)

Frequently asked questions

What is Spermosens AB (publ)'s market cap?

Spermosens AB (publ)'s market capitalization is EUR 634.60K.